Literature DB >> 24201307

Cardioprotective effect of vincristine on isoproterenol-induced myocardial necrosis in rats.

Sunanda Panda1, Anand Kar2, Vilayanoor Ramamurthy3.   

Abstract

This study investigated the protective effect of vincristine (VCR) on isoproterenol (ISO)-induced cardiac necrosis (CN) in rats. Animals (n=7 in each group) were pretreated with vincristine (25µg/kg) intraperitoneal (i.p.) daily in 5-day cycles with 2 days pause between cycles using a 5-day-on, 2-day-off schedule for two weeks and then intoxicated with isoproterenol (100mg/kg, s.c., for 2 consecutive days). ISO-induced myocardial damage was indicated by changes in electrocardiographic (ECG) patterns, increased activities of marker enzymes such as creatine kinase-MB, serum glutamate pyruvate transaminase and lactate dehydrogenase and the levels of troponin-T in the serum. The levels of lipid peroxide products, (thiobarbituric acid reactive substances (TBARS) and lipid hydroperoxides (HP)) were increased with a parallel decrease in the activities of antioxidants (superoxide dismutase, catalase, glutathione peroxidase and reduced glutathione) in ISO-induced rats. Furthermore, ISO-induced rats showed increase in the activities of membrane bound enzymes such as Ca(2+)-ATPase and Mg(2+)-ATPase with a decreased activity of Na(+)/K(+)-ATPase. Triphenyl tetrazolium chloride (TTC) staining of the heart section showed increased area of necrosis in ISO-induced rats. Pretreatment with VCR (25µg/kg) eliminated all ISO-induced biochemical and histopathological changes, and decreased the myocardial necrosis to a greater extent. Transmission electron microscopic findings on the structure of the heart mitochondria confirmed the protective effects of VCR. Present study provides first scientific report on protective effect of vincristine against ISO-induced cardiac damage in rats.
© 2013 Published by Elsevier B.V.

Entities:  

Keywords:  Cardiac necrosis; Free radicals; Isoproterenol; Transmission electron microscopy; Vincristine

Mesh:

Substances:

Year:  2013        PMID: 24201307     DOI: 10.1016/j.ejphar.2013.10.049

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Preventive effect of Agnucastoside C against Isoproterenol-induced myocardial injury.

Authors:  Sunanda Panda; Anand Kar; Sagarika Biswas
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

2.  Protective effects of Shexiang Tongxin Dropping Pill on pituitrin‑induced acute myocardial ischemia in rats.

Authors:  Shan Lin; Jianfeng Chu; Ling Zhang; Daxin Chen; Fei Xiao; Hongwei Chen; Jiumao Lin; Youqin Chen; Yuling Zhu; Jun Peng
Journal:  Mol Med Rep       Date:  2017-07-13       Impact factor: 2.952

3.  The protective role of lutein on isoproterenol-induced cardiac failure rat model through improving cardiac morphology, antioxidant status via positively regulating Nrf2/HO-1 signalling pathway.

Authors:  Bo Ouyang; Zili Li; Xiongying Ji; Jiangwei Huang; Hengsheng Zhang; Changrong Jiang
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

4.  Fuziline alleviates isoproterenol-induced myocardial injury by inhibiting ROS-triggered endoplasmic reticulum stress via PERK/eIF2α/ATF4/Chop pathway.

Authors:  Cai-Lian Fan; Zhi-Hong Yao; Meng-Nan Ye; Lei-Lei Fu; Guo-Nian Zhu; Yi Dai; Xin-Sheng Yao
Journal:  J Cell Mol Med       Date:  2019-12-07       Impact factor: 5.310

5.  Protective Effects and Mechanisms of Recombinant Human Glutathione Peroxidase 4 on Isoproterenol-Induced Myocardial Ischemia Injury.

Authors:  Chang Liu; Bozhao Li; Qi Yan; Shaopeng Niu; Yiding Zhao; Changhao Xiong; Tianjiao Zhang; Jingyan Wei
Journal:  Oxid Med Cell Longev       Date:  2021-09-07       Impact factor: 6.543

Review 6.  Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis.

Authors:  Rui Qin; Qian Zhao; Bo Han; Hong-Ping Zhu; Cheng Peng; Gu Zhan; Wei Huang
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

7.  Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats.

Authors:  Fangjie Bi; Yujia Xu; Quansan Sun
Journal:  Anatol J Cardiol       Date:  2018-05       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.